Vanguard Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$131M Buy
2,564,869
+24,808
+1% +$1.26M ﹤0.01% 1714
2025
Q1
$114M Buy
2,540,061
+115,327
+5% +$5.2M ﹤0.01% 1739
2024
Q4
$100M Sell
2,424,734
-71,378
-3% -$2.95M ﹤0.01% 1869
2024
Q3
$97.3M Buy
2,496,112
+49,379
+2% +$1.93M ﹤0.01% 1882
2024
Q2
$83.7M Buy
2,446,733
+235,048
+11% +$8.04M ﹤0.01% 1920
2024
Q1
$55.6M Sell
2,211,685
-264,559
-11% -$6.65M ﹤0.01% 2123
2023
Q4
$73.1M Buy
2,476,244
+782,901
+46% +$23.1M ﹤0.01% 2013
2023
Q3
$53.5M Buy
1,693,343
+98,685
+6% +$3.12M ﹤0.01% 2101
2023
Q2
$41.3M Buy
1,594,658
+320,831
+25% +$8.3M ﹤0.01% 2272
2023
Q1
$30.6M Buy
1,273,827
+11,529
+0.9% +$277K ﹤0.01% 2405
2022
Q4
$24.6M Buy
1,262,298
+17,373
+1% +$339K ﹤0.01% 2527
2022
Q3
$26.2M Buy
1,244,925
+261,950
+27% +$5.5M ﹤0.01% 2516
2022
Q2
$19.1M Buy
982,975
+217,791
+28% +$4.24M ﹤0.01% 2657
2022
Q1
$16.9M Sell
765,184
-43,165
-5% -$951K ﹤0.01% 2871
2021
Q4
$12.9M Buy
808,349
+73,702
+10% +$1.18M ﹤0.01% 3085
2021
Q3
$14.6M Buy
734,647
+3,150
+0.4% +$62.7K ﹤0.01% 3033
2021
Q2
$12.6M Sell
731,497
-9,377
-1% -$162K ﹤0.01% 3090
2021
Q1
$14.7M Buy
740,874
+113,078
+18% +$2.24M ﹤0.01% 2942
2020
Q4
$11M Buy
627,796
+147,712
+31% +$2.58M ﹤0.01% 2945
2020
Q3
$9.25M Buy
480,084
+7,067
+1% +$136K ﹤0.01% 2827
2020
Q2
$9.21M Buy
473,017
+299,240
+172% +$5.82M ﹤0.01% 2813
2020
Q1
$2.43M Buy
173,777
+93,344
+116% +$1.31M ﹤0.01% 3248
2019
Q4
$1.97M Sell
80,433
-1,423
-2% -$34.9K ﹤0.01% 3459
2019
Q3
$823K Buy
+81,856
New +$823K ﹤0.01% 3698